Sneddon syndrome revealing dysfibrinogenemia.
Khosrotehrani
Kiarash
K
Department of Dermatology, Hôpital Henri Mondor, Créteil Cedex, France.
Leroy-Matheron
Catherine
C
Mourier
Claude
C
Revuz
Jean
J
Bagot
Martine
M
D000328:Adult; D001241:Aspirin / Q000627:therapeutic use; D025861:Blood Coagulation Disorders, Inherited / Q000150:complications* / Q000188:drug therapy / Q000378:metabolism; D015241:Fibrinogens, Abnormal / Q000096:biosynthesis*; D005343:Fibrinolytic Agents / Q000627:therapeutic use; D006801:Humans; D018860:Sneddon Syndrome / Q000150:complications* / Q000188:drug therapy
D015241:Fibrinogens, Abnormal; D005343:Fibrinolytic Agents; D001241:Aspirin